Related Experiment Videos
Summary
Cimetidine exhibits low toxicity in animal studies, with minimal adverse effects observed even at high doses. Clinical use confirms its safety, aligning with predictions from extensive preclinical research.
Area of Science:
- Pharmacology
- Toxicology
- Gastroenterology
Background:
- Cimetidine is a widely used medication.
- Assessing the safety profile of cimetidine is crucial for patient care.
Purpose of the Study:
- To evaluate the toxicological profile of cimetidine in animal models.
- To assess the long-term safety and potential risks associated with cimetidine therapy.
Main Methods:
- Acute and repeated-dose toxicity studies in rodents and dogs.
- Carcinogenicity and reproductive toxicity studies.
- Long-term safety monitoring in clinical practice.
Main Results:
- Low acute toxicity observed in dogs and rodents.
- Minimal adverse effects in rodents, with some dose-related organ weight changes.
- Dogs at high doses showed liver and kidney changes; no such effects at lower doses.
- No evidence of carcinogenicity or significant adverse reproductive effects.
- Clinical data supports a favorable safety profile in over 30 million patients.
Conclusions:
- Cimetidine demonstrates a favorable safety profile across extensive preclinical and clinical evaluations.
- The drug is predicted and proven to be an extremely safe therapeutic agent.
- No significant risks for gastric cancer have been identified.